World

Decitabine/Cedazuridine Earns European Approval in Acute Myeloid Leukemia

Posted by September 21, 2023

The FDA approved oral decitabine and cedazuridine in adult patients with MDS in July 2020.The European Commission has approved oral decitabine and cedazuridine

Read More